ProPhase Labs
PRPH
About: ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
Employees: 96
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
500% more call options, than puts
Call options by funds: $6K | Put options by funds: $1K
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
10.27% less ownership
Funds ownership: 16.72% [Q1] → 6.45% (-10.27%) [Q2]
11% less funds holding
Funds holding: 37 [Q1] → 33 (-4) [Q2]
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
48% less capital invested
Capital invested by funds: $2.02M [Q1] → $1.05M (-$970K) [Q2]
Financial journalist opinion
Based on 4 articles about PRPH published over the past 30 days
